COVID-19 in rheumatic disease patients on immunosuppressive agents.

ABSTRACT:

Objective

To analyze clinical characteristics and outcome of COVID-19 patients with underlying rheumatic diseases (RD) on immunosuppressive agents.

Method

A case series of COVID-19 patients with RD on disease modifying anti-rheumatic drugs (DMARDs) were studied by a retrospective chart review. A literature search identified 9 similar studies of single cases and case series, which were also included.

Results

There were 4 COVID-19 inpatients with RD from our hospital, and the mean age was 57 ± 21 years. Two patients had a mild infection, and 2 developed severe COVID-19 related respiratory complications, including 1 patient on secukinumab requiring mechanical ventilation and 1 patient on rituximab developing viral pneumonia requiring supplemental oxygenation. All 4 patie

SUBMITTER: Sharmeen S 

PROVIDER: S-EPMC7245236 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature